AI Engines For more Details: Perplexity Kagi Labs You
Antioxidant Properties: Mustard seeds contain compounds such as glucosinolates, which have antioxidant properties. Antioxidants help neutralize harmful free radicals in the body, reducing oxidative stress and inflammation, which are associated with various chronic diseases like heart disease and cancer.
Digestive Aid: Mustard seeds may stimulate digestive enzymes and gastric juices, aiding digestion. Consuming mustard or mustard seeds in moderation may help alleviate indigestion, bloating, and constipation.
Anti-inflammatory Effects: Some research suggests that compounds in mustard seeds, such as isothiocyanates, may have anti-inflammatory effects. This could potentially benefit conditions characterized by inflammation, such as arthritis and inflammatory bowel diseases (IBD).
Cardiovascular Health: Mustard seeds contain omega-3 fatty acids, which are beneficial for heart health. Additionally, studies suggest that mustard seeds may help lower blood pressure and cholesterol levels, reducing the risk of cardiovascular diseases.
Respiratory Health: Mustard seeds may act as a decongestant and expectorant, helping to relieve respiratory congestion and cough. Inhaling steam from mustard seeds may provide relief from sinus congestion and other respiratory symptoms.
Antimicrobial Properties: Mustard seeds possess antimicrobial properties due to compounds like allyl isothiocyanate. These properties may help fight against bacteria and fungi, potentially reducing the risk of infections.
Pain Relief: Topical application of mustard seed paste or oil has been used traditionally to relieve muscle pain, arthritis pain, and headaches. Mustard plasters, made by mixing mustard seed powder with water and applying it to the affected area, create a warming sensation that can help alleviate pain and increase blood flow to the area.
Rank | Probiotic | Impact |
---|---|---|
species | Bacteroides uniformis | Reduces |
species | Blautia hansenii | Reduces |
species | Enterococcus durans | Reduces |
species | Enterococcus faecalis | Reduces |
species | Enterococcus faecium | Reduces |
species group | Pseudomonas putida group | Reduces |
We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.
A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.
We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive X|increases + Y|decrease = Negative.
Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.
Condition | Positive Impact | Negative Impact | Benefit Ratio Impact |
---|---|---|---|
Abdominal Aortic Aneurysm | 0.1 | 0.1 | |
Acne | 0.3 | 0.3 | |
ADHD | 0.5 | 0.5 | |
Allergic Rhinitis (Hay Fever) | 2 | 0.5 | 3 |
Allergies | 2 | 1.6 | 0.25 |
Allergy to milk products | 1.3 | 0.8 | 0.63 |
Alopecia (Hair Loss) | 0.7 | 0.7 | |
Alzheimer's disease | 2.9 | 1.1 | 1.64 |
Amyotrophic lateral sclerosis (ALS) Motor Neuron | 0.2 | 0.2 | |
Ankylosing spondylitis | 1.1 | 0.5 | 1.2 |
Anorexia Nervosa | 0.3 | 0.9 | -2 |
Antiphospholipid syndrome (APS) | 0.6 | 0.6 | |
Asthma | 2.1 | 0.8 | 1.63 |
Atherosclerosis | 0.8 | 0.3 | 1.67 |
Atrial fibrillation | 1.3 | 0.5 | 1.6 |
Autism | 2.7 | 2.1 | 0.29 |
Autoimmune Disease | 0.3 | -0.3 | |
benign prostatic hyperplasia | 0.5 | 0.5 | 0 |
Biofilm | 1.8 | 1.8 | |
Bipolar Disorder | 0.8 | 1.3 | -0.63 |
Brain Trauma | 0.1 | 1 | -9 |
Cancer (General) | 1.5 | -1.5 | |
Carcinoma | 0.5 | 0.5 | 0 |
Celiac Disease | 2.4 | 0.8 | 2 |
Cerebral Palsy | 1.4 | 0.5 | 1.8 |
Chronic Fatigue Syndrome | 2.6 | 1 | 1.6 |
Chronic Kidney Disease | 1.6 | 0.2 | 7 |
Chronic Lyme | 0.5 | 0.5 | 0 |
Chronic Obstructive Pulmonary Disease (COPD) | 1 | 1 | |
Chronic Urticaria (Hives) | 0.3 | 0.2 | 0.5 |
Coagulation / Micro clot triggering bacteria | 0.3 | 0.3 | |
Cognitive Function | 0.8 | 0.3 | 1.67 |
Colorectal Cancer | 2.2 | 1.7 | 0.29 |
Constipation | 1.4 | 1.4 | |
Coronary artery disease | 1 | 0.7 | 0.43 |
COVID-19 | 4.4 | 2.7 | 0.63 |
Crohn's Disease | 2.9 | 1.3 | 1.23 |
Cushing's Syndrome (hypercortisolism) | 0.1 | 0.5 | -4 |
cystic fibrosis | 1.8 | 0.5 | 2.6 |
d-lactic acidosis (one form of brain fog) | 0.1 | 0.1 | |
deep vein thrombosis | 0.5 | 1 | -1 |
Denture Wearers Oral Shifts | 1.3 | 1.3 | |
Depression | 2.6 | 1.2 | 1.17 |
Dermatomyositis | 0.1 | 0.1 | |
Eczema | 1.8 | 0.4 | 3.5 |
Endometriosis | 1.6 | 1.6 | |
Epilepsy | 1.7 | 0.5 | 2.4 |
erectile dysfunction | 0.8 | 0.8 | |
Fibromyalgia | 0.4 | 0.9 | -1.25 |
Functional constipation / chronic idiopathic constipation | 1.6 | 1.1 | 0.45 |
gallstone disease (gsd) | 0.9 | 0.9 | |
Gastroesophageal reflux disease (Gerd) including Barrett's esophagus | 0.3 | 0.3 | |
Generalized anxiety disorder | 1 | 0.8 | 0.25 |
giant cell arteritis | 0.3 | -0.3 | |
Gout | 1.7 | 0.3 | 4.67 |
Graves' disease | 0.5 | 0.8 | -0.6 |
Gulf War Syndrome | 0.5 | 0.3 | 0.67 |
Halitosis | 0.5 | 0.5 | |
Hashimoto's thyroiditis | 1.2 | 0.5 | 1.4 |
Heart Failure | 2.2 | 2.2 | |
Hidradenitis Suppurativa | 1.8 | 1.8 | |
High Histamine/low DAO | 1.5 | 1.5 | |
hypercholesterolemia (High Cholesterol) | 0.3 | 0.7 | -1.33 |
hyperglycemia | 0.5 | 0.5 | 0 |
Hyperlipidemia (High Blood Fats) | 0.8 | 0.8 | |
hypertension (High Blood Pressure | 1.5 | 1.8 | -0.2 |
Hypothyroidism | 0.8 | 0.8 | |
Hypoxia | 1.4 | 1.4 | |
IgA nephropathy (IgAN) | 0.6 | 1.4 | -1.33 |
Inflammatory Bowel Disease | 3.6 | 0.9 | 3 |
Insomnia | 1.3 | 0.9 | 0.44 |
Intelligence | 0.9 | 0.9 | |
Intracranial aneurysms | 0.5 | 0.5 | |
Irritable Bowel Syndrome | 3 | 1.8 | 0.67 |
ischemic stroke | 0.7 | 0.5 | 0.4 |
Liver Cirrhosis | 2.1 | 1.8 | 0.17 |
Long COVID | 1.8 | 0.9 | 1 |
Lung Cancer | 0.2 | 0.2 | |
Mast Cell Issues / mastitis | 0.8 | 0.8 | |
ME/CFS with IBS | 0.8 | 1 | -0.25 |
ME/CFS without IBS | 1.5 | 1 | 0.5 |
Menopause | 0.2 | 0.2 | |
Metabolic Syndrome | 2.4 | 2.3 | 0.04 |
Mood Disorders | 2.6 | 2.4 | 0.08 |
Multiple Sclerosis | 1.4 | 1.6 | -0.14 |
Multiple system atrophy (MSA) | 0.2 | 0.2 | |
myasthenia gravis | 0.3 | -0.3 | |
neuropathic pain | 0.5 | -0.5 | |
neuropsychiatric disorders (PANDAS, PANS) | 0.3 | 0.3 | |
Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic | 1.6 | 0.5 | 2.2 |
NonCeliac Gluten Sensitivity | 0.5 | 0.5 | 0 |
Obesity | 2.2 | 1.7 | 0.29 |
obsessive-compulsive disorder | 2.5 | 1 | 1.5 |
Osteoarthritis | 1.1 | 0.5 | 1.2 |
Osteoporosis | 1.1 | 0.5 | 1.2 |
pancreatic cancer | 0.8 | 0.8 | |
Parkinson's Disease | 2.9 | 0.9 | 2.22 |
Polycystic ovary syndrome | 1.7 | 1 | 0.7 |
Postural orthostatic tachycardia syndrome | 0.3 | 0.3 | |
primary biliary cholangitis | 1 | 0.7 | 0.43 |
Primary sclerosing cholangitis | 1.6 | 0.3 | 4.33 |
Psoriasis | 1.6 | 0.5 | 2.2 |
rheumatoid arthritis (RA),Spondyloarthritis (SpA) | 2.9 | 1.9 | 0.53 |
Rosacea | 0.7 | 0.3 | 1.33 |
Schizophrenia | 2.1 | 1.5 | 0.4 |
scoliosis | 0.1 | 0.1 | |
sensorineural hearing loss | 0.3 | 0.3 | |
Sjögren syndrome | 0.7 | -0.7 | |
Sleep Apnea | 0.2 | 0.5 | -1.5 |
Slow gastric motility / Gastroparesis | 0.5 | 0.5 | |
Small Intestinal Bacterial Overgrowth (SIBO) | 2.1 | 0 | 0 |
Stress / posttraumatic stress disorder | 1.8 | 0.7 | 1.57 |
Systemic Lupus Erythematosus | 2.2 | 0.5 | 3.4 |
Tic Disorder | 0.1 | -0.1 | |
Tourette syndrome | 0.5 | -0.5 | |
Type 1 Diabetes | 1.7 | 1.3 | 0.31 |
Type 2 Diabetes | 2.2 | 1.7 | 0.29 |
Ulcerative colitis | 3 | 3.1 | -0.03 |
Unhealthy Ageing | 1.7 | 1.7 | |
Vitiligo | 0.7 | 0.4 | 0.75 |
Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.
Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served. Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license. Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models. Inventions /Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions,
or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]